Enrolled
| SENATE RESOLUTION NO. 515 | ||
| WHEREAS, Focal segmental glomerulosclerosis is a rare | ||
| condition that frequently leads to chronic kidney disease and | ||
| kidney failure; and | ||
| WHEREAS, FSGS causes scarring in the glomeruli, the small | ||
| filters in the kidney that remove waste from the blood; it often | ||
| progresses rapidly to kidney failure, with half of FSGS patients | ||
| requiring dialysis or a kidney transplant within 5 to 10 years of | ||
| diagnosis; and | ||
| WHEREAS, According to the RaDaR Database, patients with | ||
| rare kidney conditions such as FSGS make up just 5 to 10 percent | ||
| of chronic kidney disease patients but account for approximately | ||
| 30 percent of kidney failure; and | ||
| WHEREAS, Commonly diagnosed in adulthood and most | ||
| prevalent in individuals over age 45, FSGS occurs in certain | ||
| populations, including those with African ancestry, at much | ||
| higher rates than in the general population; many patients face | ||
| delays in being diagnosed with FSGS, due to the difficulty of | ||
| rare disease diagnosis, which takes an average of five to seven | ||
| years, and the limited availability of specialized care for rare | ||
| kidney diseases; moreover, some FSGS patients experience delays | ||
| in accessing kidney transplants; and | ||
| WHEREAS, FSGS imposes a heavy burden on the U.S. health | ||
| care system; a 2019 study estimated that the disease costs public | ||
| and private health insurers about $2 billion annually; and | ||
| WHEREAS, There is new hope for patients with FSGS, with | ||
| clinical trials underway for products that may delay the | ||
| progression of FSGS and the onset of kidney disease; patients, | ||
| families, health care providers, researchers, and advocacy | ||
| organizations like NephCure and the Texas Kidney Foundation are | ||
| working tirelessly to promote early detection and to develop | ||
| innovative therapies for FSGS and other rare kidney diseases; a | ||
| patient-led and community-based organization, the Texas Kidney | ||
| Foundation conducts comprehensive kidney screenings as well as | ||
| genetic testing specifically focused on identifying rare kidney | ||
| diseases, including more than 300 rare and chronic kidney | ||
| conditions; through these innovative efforts, the foundation plays | ||
| a vital and unique role in advancing early diagnosis, empowering | ||
| patients through education and awareness, and expanding statewide | ||
| access to personalized and proactive treatment options; and | ||
| WHEREAS, FSGS Awareness Day serves as an important means to | ||
| inform the public and the medical community about this deadly | ||
| disease, to provide support and inspiration to FSGS patients and | ||
| their families, and to promote better access to diagnosis and | ||
| treatment; now, therefore, be it | ||
| RESOLVED, That the Senate of the State of Texas, 89th | ||
| Legislature, hereby recognize June 10, 2025, as FSGS Awareness Day. | ||
| Campbell | ||
| ________________________________ | ||
| President of the Senate | ||
| I hereby certify that the | ||
| above Resolution was adopted by | ||
| the Senate on May 14, 2025. | ||
| ________________________________ | ||
| Secretary of the Senate | ||
| ________________________________ | ||
| Member, Texas Senate |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.